You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

~ Buy the GLYCINE Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

Glycine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for glycine and what is the scope of patent protection?

Glycine is the generic ingredient in two branded drugs marketed by Baxter Hlthcare, B Braun, Hospira, and Icu Medical Inc, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty drug master file entries for glycine. Three suppliers are listed for this compound.

Summary for glycine
US Patents:0
Tradenames:2
Applicants:4
NDAs:5
Drug Master File Entries: 30
Finished Product Suppliers / Packagers: 3
Raw Ingredient (Bulk) Api Vendors: 265
Clinical Trials: 132
Patent Applications: 819
What excipients (inactive ingredients) are in glycine?glycine excipients list
DailyMed Link:glycine at DailyMed
Recent Clinical Trials for glycine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute on Aging (NIA)Phase 4
Vanderbilt University Medical CenterPhase 4
Bristol-Myers SquibbPhase 1/Phase 2

See all glycine clinical trials

Medical Subject Heading (MeSH) Categories for glycine

US Patents and Regulatory Information for glycine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira GLYCINE 1.5% IN PLASTIC CONTAINER glycine SOLUTION;IRRIGATION 017633-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Icu Medical Inc GLYCINE 1.5% IN PLASTIC CONTAINER glycine SOLUTION;IRRIGATION 018315-001 Approved Prior to Jan 1, 1982 AT RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Baxter Hlthcare AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER glycine SOLUTION;IRRIGATION 017865-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Baxter Hlthcare GLYCINE 1.5% IN PLASTIC CONTAINER glycine SOLUTION;IRRIGATION 018522-001 Feb 19, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
B Braun GLYCINE 1.5% IN PLASTIC CONTAINER glycine SOLUTION;IRRIGATION 016784-001 Approved Prior to Jan 1, 1982 AT RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Glycine Market Analysis and Financial Projection Experimental

The Glycine Market: Dynamics, Financial Trajectory, and Future Prospects

Market Overview

The glycine market is experiencing significant growth, driven by the compound's versatile applications across various industries. Glycine, a basic amino acid, is essential for many industrial and biological processes, making it a crucial component in multiple sectors[2].

Growth Drivers

Several factors are propelling the glycine market forward:

Increasing Demand in Health and Pharmaceuticals

Glycine's health benefits are being explored in new areas, including its potential to manage conditions like diabetes, metabolic disorders, and mental health issues. Its role in blood sugar regulation and calming effects on the central nervous system make it a promising adjunct treatment for various health conditions[2].

Food and Beverage Industry

In the food sector, glycine is used as a flavor enhancer and preservative, particularly in processed foods to enhance savory or umami flavors. The growing trend toward health-conscious eating has increased demand for glycine in functional foods and beverages, such as protein bars, shakes, and fortified snacks[2].

Industrial Applications

Glycine is widely used in manufacturing processes, including the production of pharmaceuticals, cosmetics, and chemical intermediates. Its role as a chelator in chemical reactions is crucial in industries that rely on the synthesis of high-purity compounds[2].

Market Size and CAGR

The global glycine market was valued at approximately USD 3 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of around 3.4% to 4.1% over the next decade. By 2030, the market size is expected to reach nearly USD 1.02 billion[1][4].

Regional Analysis

Geographically, the Asia Pacific region holds a dominant market share due to the presence of highly populated countries like China and India, which are driving the growth of the food and pharmaceutical industries. North America is the second-largest market, driven by the high demand for packaged food and meat products, as well as the presence of major key players[4].

Key Applications

Pharmaceuticals

Glycine is widely utilized in the pharmaceutical sector, particularly in the manufacturing of new drugs. The growing concerns related to human diseases and the increasing population, especially in the Asia Pacific, are boosting the segment's growth[4].

Food and Beverage

Glycine's use as a flavor enhancer and preservative in processed foods, soft drinks, and juice concentrates is significant. The trend toward clean label products and health-conscious eating is driving demand in this sector[2][4].

Feed Industry

The feed industry segment has led the global glycine market growth, driven by the rising ownership of pet animals and the growing trend of pet humanization. Glycine is used in animal feed to support health and growth[4].

Industrial and Manufacturing

Glycine's role in manufacturing processes, including the production of cosmetics and chemical intermediates, is critical. The trend toward sustainable manufacturing is leading to increased investments in bio-based glycine production[2].

Challenges and Restraints

Despite the growth, the glycine market faces several challenges:

Volatile Pricing

Fluctuations in raw material prices can impact the cost of glycine production, affecting market stability[1][4].

Intense Competition

The market is highly competitive, with multiple players vying for market share. This competition can lead to pricing pressures and market volatility[1].

Regulatory Hurdles

Stringent environmental regulations and health safety standards can hamper the market growth. High consumption of glycine can cause side effects like nausea, mild dizziness, and mild wheezing, which may also restrain market growth[4].

Strategic Initiatives and Innovations

To address these challenges, companies are adopting several strategies:

Strategic Partnerships and Alliances

Businesses are entering strategic partnerships to expand production and distribution networks, leveraging local demand and reducing supply chain costs[2].

Sustainable Manufacturing

There is a growing trend toward sustainable manufacturing, with companies investing in bio-based glycine production to reduce the environmental footprint associated with traditional synthesis methods[2].

Regional Expansion

Global players are focusing on acquiring regional production facilities in emerging markets to capitalize on local demand and reduce costs[2].

Future Prospects

The glycine market presents a wealth of opportunities for businesses and investors. Here are some key future prospects:

Health Supplements and Functional Foods

The growing demand for health supplements and functional foods is expected to continue, driven by consumer preferences for health-oriented products[2].

Pharmaceutical Innovations

The pharmaceutical sector is expected to continue its upward trajectory, driven by the growing need for new treatments and the increasing use of glycine in drug development[2].

Sustainable Production

The trend toward sustainable manufacturing is expected to continue, with more companies adopting bio-based glycine production methods to align with consumer preferences for eco-friendly products[2].

Key Takeaways

  • The glycine market is growing at a CAGR of 3.4% to 4.1% and is expected to reach nearly USD 1.02 billion by 2030.
  • Key drivers include increasing demand in health supplements, food and beverage products, pharmaceuticals, and industrial applications.
  • The Asia Pacific region holds a dominant market share, followed by North America.
  • Challenges include volatile pricing, intense competition, and regulatory hurdles.
  • Companies are adopting strategic partnerships, sustainable manufacturing, and regional expansion to address these challenges.

FAQs

What is the expected CAGR of the glycine market by 2030?

The glycine market is expected to grow at a CAGR of around 3.4% to 4.1% by 2030[1][4].

What are the primary applications of glycine?

Glycine is used in pharmaceuticals, food and beverage production, industrial manufacturing, and as a feed additive[2][4].

Which region holds the dominant market share in the glycine market?

The Asia Pacific region holds the dominant market share, driven by the presence of highly populated countries like China and India[4].

What are the main challenges facing the glycine market?

The main challenges include volatile pricing, intense competition, and regulatory hurdles[1][4].

How is the trend toward sustainable manufacturing impacting the glycine market?

The trend toward sustainable manufacturing is leading to increased investments in bio-based glycine production, reducing the environmental footprint associated with traditional synthesis methods[2].

Sources

  1. The Insight Partners, "Glycine Market Updates by 2031".
  2. Market Research Intellect, "Glycine Market Booms: Applications in Health, Food, and Manufacturing Propel Growth".
  3. Business Research Insights, "Capryloyl Glycine Market Size, Share, Growth, Forecast 2032".
  4. Maximize Market Research, "Glycine Market - Global Industry Analysis and Forecast (2024-2030)".

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.